More articles from Volume 27, Issue 1, 2011
OrIGINaLNI radOVI OrIGINaL arTICLEs Pathologic findings and clinical outcome in patients undergoing retroperitoneal lymphadenectomy after multiple chemorherapy regimens for metastatic nonseminomatous testicular tumors
OrIGINaLNI radOVI OrIGINaL arTICLEs Praktični aspekti serološkog testiranja D weak fenotipa
Value of preoperativne levels CEA and CA 19-9 tumor markers in patients with colorectal carcinoma compering with number of lymph node metastasis
Schwanomas and Meningiomas -The most common tumors in CPA and clinical significance
OrIGINaLNI radOVI OrIGINaL arTICLEs Pure testicular teratoma in adults: experience in the treatment of 49 consecutive cases
Article views
KONTINUIraNa MEdICINsKa EdUKaCIja The significance of screening and prenatal diagnosis of congenital heart disease
,
Milan Perovic
Zeljana Marinkovic
Published: 01.12.2010.
Biochemistry
Volume 27, Issue 1 (2011)
pp. 243-251;
Abstract
Keywords
References
1.
Ferencz C, Ca L, Ca M. Congenital Heart disease -The Baltimore-Washington Infant study 1981-9. 1993;
2.
Allan Ld, Benacerraf B, Copel J, Carvalho Ac, Chaoui R, Eik-Nes S. Isolated major congenital heart disease. Ultrasound Obstet Gynecol. 2001;370–9.
3.
Gertis L. Cardiac malformations in spontaneous abortions. Int j Cardiol. 1985;29–35.
4.
Buskens E, De G, Mulder F, Stewart Pa I, Wladimiroff Jw. Efficacy of routine fetal ultrasound screening for congenital heart disease in normal pregnancy. Circulation. 1996;(1):67–72.
5.
Office for National statistics Mortality statistics Childhood, infancy and perinatal series dH. 2002;
6.
Bull C. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. British Paediatric Cardiac association. Lancet. 1999;(9186):1242–7.
7.
Glaser J, Gelernter I, Hegesh, Yagel S. Extended fetal echocardiographic examination for detecting cardiac malformations in low risk pregnancies. Bmj. 1992;(6828):671–4.
8.
Br B. sonographic detection of fetal anomalies of the aortic and pulmonary arteries: value of four-chamber view vs direct images. am j roent. 1994;(6):14831489.
9.
Bromley B, Estroff J, Frigoletto Fd J. Fetal echocardiography: accuracy and limitations in a population at high and low risk for heart defects. am j Obstet Gynecol. 1992;(5):1473–81.
10.
Kirk Js, Riggs T, Comstock C, Lee W, Ss Y, Weinhouse E. Prenatal screening for cardiac anomalies: the value of routine addition of the aortic root to the four-chamber view. Obstet Gynecol. 1994;(3):427–31.
11.
Brown KL. Delayed diagnosis of congenital heart disease worsens preoperative condition and outcome of surgery in neonates. Heart. 2006;92(9):1298–302.
12.
Wernovsky G, Shillingford A, Gaynor J. Central nervous system outcomes in children with complex congenital heart disease. Curr Opin Cardiol. 2005;94–9.
13.
Miller S, Mcquillen P, Vigneron D, Glidden D, Barkovich J, Ferriero D, Hamrick, Karl T.
14.
Copel Ja, Pilu G, Cs K. Congenital heart disease and extracardiac anomalies: associations and indications for fetal echocardiography. am j Obstet Gynecol. 1986;(5):1121–32.
15.
Hyett Ja, Moscoso G, Papapanagiotou G, Perdu M, Nicolaides K. abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation. Ultrasound Obstet Gynecol. 1996;(4):245–50.
16.
Little, Bryan E. Congenital anomalies in twins sernin Perinatol. 1986;(1):50–64.
17.
Todros T, Faggiano F, Chiappa E, Gaglioti P. Mitola B, sciarrone a. accuracy of routine ultrasonography in screening heart disease prenatally. Gruppo Piemontese for Prenatal screening of Congenital Heart disease. Prenat diagn. 1997;(10):901–6.
18.
Tegnander E, Sh EN, Johansen Oj L, Dt. Prenatal detection of heart defects at the routine fetal examination at 18 weeks in a nonselected population. Ultrasound Obstet Gynecol. 1995;(6):372–80.
19.
Ea M. Pyeritz rE. assessment of genetic risk in congenital heart disease. j am Coll Cardiol. 1991;(2):311–42.
20.
Jj N, Ah N. Maternal transmission of congenital heart diseases: new recurrence risk figures and the questions of cytoplasmic inheritance and vulnerability to teratogens. am j Cardiol. 1987;459–63.
21.
Jj N. Causes of congenital heart disease: old and new modes, mechanisms, and models. Heart j. 1993;(5):1409–19.
22.
Mj C, Ma E, Tarnoff H. asymmetric septal hypertrophy in infants of diabetic mothers. Fetal echocardiography and the impact of maternal diabetic control. am j dis Child. 1992;(2):226–9.
23.
Rizzo G. accelerated cardiac growth and abnormal cardiac flow in fetuses of type I diabetic mothers. Obstet Gynecol. 1992;(3):369–76.
24.
Hyett Ja, Perdu M, Nicolaides K. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects. Ultrasound Obstet Gynecol. 1997;242–6.
25.
Hyett Ja, Perdu M, Nicolaides K. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ. 1999;81–5.
26.
Noble P, Nicolaides K. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet. 1998;343–6.
27.
Yagel S, Cohen Sm. Examination of the fetal heart by five shortaxis views: a proposed screening method for comprehensive cardiac evaluation. Ultrasound Obstet Gynecol. 2001;367–9.
28.
Makrydimas G. Ioannidis jP. screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis. Am J Obstet Gynecol. 2003;1330–5.
29.
Allan Ld. Echocardiographic detection of congenital heart disease in the fetus: present and future. Br Heart J. 1995;103–6.
30.
Atzei A, Gajewska K, Huggon IC, Allan L, Nicolaides KH. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype. Ultrasound in Obstetrics & Gynecology. 2005;26(2):154–7.
31.
Wimmer M, Bernaschek G. Effect of detailed fetal echocardiography as part of prenatal ultrasonographic screening on detection of congenital heart disease. Lancet. 1996;854–7.
32.
Wj O. The accuracy of antenatal fetal echocardiography screening in high-and low-risk patients. Am J Obstet Gynecol. 1995;1741–9.
33.
Wyllie J, Wren C, Hunter S. screening for fetal cardiac malformations. Br Heart J. 1994;20–7.
34.
Yagel S, Weissman A, Rotstein Z, Manor M, Hegesh E, Lipitz. Congenital heart defects: natural course and in utero development. Circulation. 1997;550–5.
35.
Yagel. Transvaginal sonography at early pregnancy cannot replace midtrimester targeted organ ultrasound examination in a high-risk population. Am J Obstet Gynecol. 1995;971–5.
36.
Lee W. american Institute of Ultrasound in Medicine. Performance of the basic fetal cardiac ultrasound examination. Ultrasound Med. 1998;796.
37.
American Institute Of Ultrasound In Medicine. Guidelines for the performance of the antepartum obstetrical ultrasound examination. Ultrasound Med. 2003;1116–25.
38.
american College of radiology. aCr practice guideline for the performance of antepartum obstetrical ultrasound. 2004;689–95.
39.
american College of Obstetricians and Gynecologists. aCOG Practice Bulletin. Ultrasonography in pregnancy. Obstet Gynecol. 2004;1449–58.
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Article metrics
Google scholar:
See link
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
